%0
Generic
%T
Abstract PD10-02: Patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel + trastuzumab (TH) (ATEMPT) trial (TBCRC 033)
%A Partridge, Ann
%A Zheng, Yue
%A Rosenberg, Shoshana
%A Gelber, Richard
%A Gelber, Shari
%A Barry, William
%A Dang, Chau
%A Yardley, Denise
%A Isakoff, Steven
%A Valero, Vicente
%A Faggen, Meredith
%A Mulvey, Therese
%A Bose, Ron
%A Weckstein, Douglas
%A Wolff, Antonio
%A Reeder-Hayes, Katherine
%A Rugo, Hope
%A Ramaswamy, Bhuvaneswari
%A Zuckerman, Dan
%A Hart, Lowell
%A Gadi, Vijayakrishna
%A Constantine, Michael
%A Cheng, Kit
%A Briccetti, Frederick
%A Schneider, Bryan
%A Garrett, Merrill
%A Marcom, P. Kelly
%A Albain, Kathy
%A Defusco, Patricia
%A Tung, Nadine
%A Ardman, Blair
%A Nanda, Rita
%A Jankowitz, Rachel
%A DeMeo, Michelle
%A Burstein, Harold
%A Winer, Eric P.
%A Krop, Ian
%A Tolaney, Sara
%I American Association for Cancer Research (AACR)
%@ 0008-5472
%@ 1538-7445
%K Cancer Research
%K Oncology
%D 2020
%C American Association for Cancer Research (AACR)
%U http://slubdd.de/katalog?TN_libero_mab2